← Leaderboards
Barbara J Klencke
University Of California San Francisco
$274,664
Attributed
$274,664
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$274,664 · 2
By mechanism
M01$274,664 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Joel Palefsky$28,104,336
- Katherine Kurshan Matthay$7,757,759
- Marcus Aaron Horwitz$40,522,782
- Anna-Barbara None Moscicki$36,508,762
- Ruth Martha Greenblatt$14,541,651
Others in their field
Top investigators on “Clinical Trial Phase I”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Lawrence Corey · Fred Hutchinson Cancer Center$674,722,986
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$549,289,302
- Barton F Haynes · Duke University$532,133,792
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$407,280,377
Research focus
Clinical Trial Phase INeoplasm /Cancer ImmunotherapyHuman PapillomavirusPreneoplastic StateRectum NeoplasmsSquamous Cell CarcinomaHuman SubjectViral VaccinesHuman Therapy EvaluationClinical ResearchVirus Related Neoplasm /CancerAntiviral AgentsDosageDrug Screening /EvaluationInjection /InfusionNeoplasm /Cancer ChemotherapyP53 Gene /ProteinVector VaccineAids Related Neoplasm /Cancer
Grant awards (8)
ONYX-015 for HIV associated preinvasive anal carcinoma$68,666
M01 · FY2002 · RR
Plasmid DNA vaccine to HPV-16 for anal dysplasia$68,666
M01 · FY2002 · RR
Plasmid DNA vaccine to HPV-16 for anal dysplasia$68,666
M01 · FY2001 · RR
ONYX-015 for HIV associated preinvasive anal carcinoma$68,666
M01 · FY2001 · RR
Plasmid DNA vaccine to HPV-16 for anal dysplasia$0
M01 · FY2001 · RR
ONYX-015 for HIV associated preinvasive anal carcinoma$0
M01 · FY2001 · RR
ONYX-015 for HIV associated preinvasive anal carcinoma$0
M01 · FY2000 · RR
Plasmid DNA vaccine to HPV-16 for anal dysplasia$0
M01 · FY2000 · RR